The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Open accessAbstract
We investigated SARS-CoV-2 potential tropism by surveying expression of viral entry-associated genes in single-cell RNA-sequencing data from multiple tissues from healthy human donors. We co-detected these transcripts in specific respiratory, corneal and intestinal epithelial cells, potentially explaining the high efficiency of SARS-CoV-2 transmission. These genes are co-expressed in nasal epithelial cells with genes involved in innate immunity, highlighting the cells’ potential role in initial viral infection, spread and clearance. The study offers a useful resource for further lines of inquiry with valuable clinical samples from COVID-19 patients and we provide our data in a comprehensive, open and user-friendly fashion at www.covid19cellatlas.org . An analysis of single-cell transcriptomics datasets from different tissues shows that ACE2 and TMPRSS2 are co-expressed in respiratory, corneal and intestinal epithelial cell populations, and that respiratory expression of ACE2 is associated with genes involved in innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although scSeq revealed ACE2 transcripts in only a subset of OE cells, this low level of observed expression matches or exceeds that observed in respiratory cells types that are infected by CoV-2 in COVID-19 patients (39) (Fig. 3).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Experimental — accuracy not yet measuredIn the citing paper
“Probably most important for the high efficacy of SARS-CoV-2 transmission is the high co-expression of ACE2 and TMPRSS2 in nasal epithelial cells, particularly in two types of goblet cells and a subset of ciliated cells, showing the highest expression among all cells in the respiratory tree (Figure 2 A).”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“An interesting observation of this study was the high co-expression of genes involved in early steps of antiviral immune responses in these epithelial cells, which indicated the potential for these specialized nasal cells to play an important role in the initial viral infection, spread, but potentially also, clearance.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“TMPRSS2 is more widely expressed than ACE2, and cells with simultaneous expression were identified in the respiratory tree, the cornea, esophagus, ileum, colon, gallbladder, and common bile duct (Sungnak et al., 2020), yet there was no evidence for simultaneous expression in immune cells.”
From COVID-19 and the human innate immune system (2021) · cites this paper as Sungnak et al., 2020
In the citing paper
“It has recently been demonstrated through single cell RNA sequencing analysis (referred to herein as scSeq) that cells from the human upper airway — including nasal RE goblet and ciliated cells —express high levels of ACE2 and TMPRSS2, suggesting that these RE cell types may serve as a viral reservoir during CoV-2 infection (39, 40).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Clinical Characteristics of Coronavirus Disease 2019 in China
Eastin, C., & Eastin, T. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.004 · Cited by 24,945
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Fast, sensitive and accurate integration of single-cell data with Harmony
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488
Cited by
Sorted by citations
Items 601–700 of 1,000
Translational adaptation of human viruses to the tissues they infect
Hernandez‐Alias, X., Benisty, H., Schaefer, M. H., & Serrano, L. G. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108872 · Cited by 45
Villena, J., Li, C., Vizoso-Pinto, M. G., Sacur, J., Ren, L., & Kitazawa, H. (2021) · Microorganisms · doi:10.3390/microorganisms9040683 · Cited by 45
SARS-CoV-2 Infection Triggers Phosphorylation: Potential Target for Anti-COVID-19 Therapeutics
Chatterjee, B., & Thakur, S. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829474 · Cited by 45
Modelling airborne transmission of SARS-CoV-2 using CARA: risk assessment for enclosed spaces
Henriques, A., Mounet, N., Aleixo, L., Elson, P., Devine, J., Azzopardi, G., Andreini, M., Rognlien, M., Tarocco, N., & Tang, J. W.-T. (2022) · Interface Focus · doi:10.1098/rsfs.2021.0076 · Cited by 50
Valyaeva, A. A., Zharikova, A. A., Kasianov, A. S., Vassetzky, Y. S., & Sheval, E. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-74598-5 · Cited by 46
Kantarcıoğlu, B., Iqbal, O., Walenga, J. M., Lewis, B., Lewis, J., Carter, C. A., Singh, M., Lievano, F. A., Tafur, A. J., Ramacciotti, E., et al. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211021498 · Cited by 45
Long-term effects of SARS-CoV-2 infection on human brain and memory
Ding, Q., & Zhao, H. T. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01512-z · Cited by 45
Paladino, L., Vitale, A. M., Bavisotto, C. C., de Macario, E. C., Cappello, F., Macario, A. J. L., & Marino, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113518 · Cited by 44
Kidney ACE2 expression: Implications for chronic kidney disease
Maksimowski, N. A., Williams, V. R., & Scholey, J. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241534 · Cited by 44
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
Fröberg, J., & Diavatopoulos, D. A. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000724 · Cited by 45
Siniscalchi, C., Palo, A. D., Russo, A., & Potenza, N. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.678994 · Cited by 45
No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing
Smits, N., Rasmussen, J., Bodea, G. O., Amarilla, A. A., Gerdes, P., Sanchez-Luque, F. J., Ajjikuttira, P., Modhiran, N., Liang, B., Faivre, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109530 · Cited by 46
Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids
Chen, K. G., Park, K., & Spence, J. R. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00721-x · Cited by 45
Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection
Kim, H. K., Kim, H., Lee, M. K., Choi, W. H., Jang, Y., Shin, J. S., Park, J.-Y., Bae, D. H., Hyun, S., Kim, K. H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121460 · Cited by 44
Neuroinvasion of SARS‐CoV‐2 may play a role in the breakdown of the respiratory center of the brain
Dey, J., Alam, M. T., Chandra, S., Gupta, J., Ray, U., Srivastava, A. K., & Tripathi, P. P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26521 · Cited by 43
Potential of Ocular Transmission of SARS-CoV-2: A Review
Barnett, B. P., Wahlin, K. J., Krawczyk, M., Spencer, D., Welsbie, D. S., Afshari, N. A., & Chao, D. L. (2020) · Vision · doi:10.3390/vision4030040 · Cited by 43
Konstantinidis, I., Delides, A., Tsakiropoulou, E., Maragoudakis, P., Sapounas, S., & Tsiodras, S. (2020) · ORL · doi:10.1159/000511436 · Cited by 43
Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma
Kermani, N. Z., Song, W., Lunt, A., Badi, Y. E., Versi, A., Guo, Y., Sun, K., Bhavsar, P., Howarth, P., Dahlén, S.-E., et al. (2021) · Respiratory Research · doi:10.1186/s12931-020-01605-8 · Cited by 44
Bui, L. T., Winters, N. I., Chung, M.-I., Joseph, C., Gutierrez, A. J., Habermann, A. C., Adams, T. S., Schupp, J. C., Poli, S., Peter, L. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24467-0 · Cited by 45
Self-citationVecchio, A. L., Garazzino, S., Smarrazzo, A., Venturini, E., Poeta, M., Berlese, P., Denina, M., Meini, A., Bosis, S., Galli, L., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.39974 · Cited by 43
Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways
Tam, A., Kulkarni, J. A., An, K., Li, L., Dorscheid, D. R., Singhera, G. K., Bernatchez, P. N., Reid, G. S. D., Chan, K. Y. T., Witzigmann, D., et al. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106234 · Cited by 44
Yasamineh, S., Kalajahi, H. G., Yasamineh, P., Gholizadeh, O., Youshanlouei, H. R., Matloub, S. K., Mozafari, M., Jokar, E., Yazdani, Y., & Dadashpour, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02944-7 · Cited by 44
Human transferrin receptor can mediate SARS-CoV-2 infection
Liao, Z., Wang, C., Tang, X., Yang, M., Duan, Z., Liu, L., Lu, S., Ma, L., Cheng, R., Gan, W., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317026121 · Cited by 45
Deciphering SARS-CoV-2 Virologic and Immunologic Features
Lebeau, G., Vagner, D., Frumence, É., Ah-Pine, F., Guillot, X., Nobécourt, E., Raffray, L., & Gasque, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165932 · Cited by 54
Casagrande, M. K., Fitzek, A., Spitzer, M. S., Püschel, K., Glatzel, M., Krasemann, S., Aepfelbacher, M., Nörz, D. S., Lütgehetmann, M., Pfefferle, S., et al. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-318618 · Cited by 43
Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?
Rossi, G. A., Sacco, O., Capizzi, A., & Mastromarino, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670955 · Cited by 43
Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides
Dhanjal, J. K., Kumar, V., Garg, S., Subramani, C., Agarwal, S., Wang, J., Zhang, H., Kaul, A., Kalra, R. S., Kaul, S. C., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.015 · Cited by 43
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
Liao, M.-T., Wu, C., Wu, S. V., Lee, M., Hu, W., Tsai, K., Yang, C., Lu, C., Chiu, S.-K., & Lu, K. (2021) · Antioxidants · doi:10.3390/antiox10091440 · Cited by 46
Review of Oxygenation with Nanobubbles: Possible Treatment for Hypoxic COVID-19 Patients
Afshari, R., Akhavan, O., Hamblin, M. R., & Varma, R. S. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c01907 · Cited by 43
Kirtipal, N., Kumar, S., Dubey, S. K., Dwivedi, V. D., Babu, K. G., Malý, P., & Bharadwaj, S. (2022) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2022.105254 · Cited by 44
Sang, E. R., Tian, Y., Miller, L. C., & Sang, Y. (2021) · Genes · doi:10.3390/genes12020154 · Cited by 42
Evidence of SARS-CoV-2 Transmission Through the Ocular Route
Qu, J., Xie, H.-T., & Zhang, M. (2021) · Clinical ophthalmology · doi:10.2147/opth.s295283 · Cited by 42
Sivandzadeh, G. R., Askari, H., Safarpour, A. R., Ejtehadi, F., Raeis-Abdollahi, E., Armaghan Vaez, L. A. R. I., Abazari, M. F., Tarkesh, F., & Lankarani, K. B. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i22.6178 · Cited by 42
Ellison, G. M., Colley, L. S., O’Brien, K. A., Roberts, K. A., Agbaedeng, T. A., & Ross, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.602183 · Cited by 42
Rajput, S. K., Logsdon, D. M., Kile, B., Engelhorn, H. J., Goheen, B. B., Khan, S. A., Swain, J. E., McCormick, S., Schoolcraft, W. B., Yuan, Y., et al. (2020) · F&S Science · doi:10.1016/j.xfss.2020.12.005 · Cited by 42
Hanna, R., Dalvi, S., Sălăgean, T., Pop, I., Bordea, I. R., & Benedicenti, S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s282213 · Cited by 42
Expression of SARS‐CoV‐2 entry factors in human oral tissue
Sawa, Y., Ibaragi, S., Okui, T., Yamashita, J., Ikebe, T., & Harada, H. (2021) · Journal of Anatomy · doi:10.1111/joa.13391 · Cited by 42
Persson, E., Castresana-Aguirre, M., Buzzao, D., Guala, D., & Sonnhammer, E. L. L. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166835 · Cited by 42
In the eye of the storm: SARS‐CoV‐2 infection and replication at the ocular surface?
Armstrong, L., Collin, J., Mostafa, I., Queen, R. A., Figueiredo, F. C., & Lako, M. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0543 · Cited by 43
Self-citationState-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2
Derakhshan, M. A., Amani, A., & Majidi, R. F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c22381 · Cited by 42
García-Nicolás, O., V’kovski, P., Zettl, F., Zimmer, G., Thiel, V., & Summerfield, A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.644574 · Cited by 48
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 43
Long-chain polyphosphates impair SARS-CoV-2 infection and replication
Ferrucci, V., Kong, D.-Y., Asadzadeh, F., Marrone, L., Boccia, A. S., Siciliano, R., Criscuolo, G., Anastasio, C., Quarantelli, F., Comegna, M., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abe5040 · Cited by 44
Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases
Fitzek, A., Schädler, J., Dietz, E., Ron, A., Gerling, M., Kammal, A. L., Lohner, L., Falck, C., Möbius, D., Goebels, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98499-3 · Cited by 42
Frumkin, L. R., Lucas, M., Scribner, C. L., Ortega-Heinly, N., Rogers, J., Yin, G., Hallam, T. J., Yam, A. Y.-W., Bedard, K., Begley, R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.899617 · Cited by 42
Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19
Huijghebaert, S., Hoste, L., & Vanham, G. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03102-3 · Cited by 46
Nasally inhaled therapeutics and vaccination for COVID‐19: Developments and challenges
Xi, J., Lei, L. R., Zouzas, W., & Si, X. A. (2021) · MedComm · doi:10.1002/mco2.101 · Cited by 45
Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
Stölting, H., Baillon, L., Frise, R., Bonner, K., Hewitt, R. J., Molyneaux, P. L., Gore, M. L., Barclay, W., Saglani, S., & Lloyd, C. M. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00545-4 · Cited by 43
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
Bruzzone, C., Conde, R., Embade, N., Mato, J. M., & Millet, Ó. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1111482 · Cited by 43
SARS-CoV-2 (COVID-19): New Discoveries and Current Challenges
Soufi, G. J., Hekmatnia, A., Nasrollahzadeh, M., Shafiei, N., Sajjadi, M., Iravani, P., Fallah, S., Iravani, S., & Varma, R. S. (2020) · Applied Sciences · doi:10.3390/app10103641 · Cited by 41
Aerosol Generation during Spirometry
Helgeson, S. A., Lim, K. G., Lee, A. S., Niven, A. S., & Patel, N. M. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-569rl · Cited by 41
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106980 · Cited by 42
Vastrad, B. M., Vastrad, C. M., & Tengli, A. (2020) · 3 Biotech · doi:10.1007/s13205-020-02406-y · Cited by 41
Mechanisms of COVID‐19‐induced cardiovascular disease: Is sepsis or exosome the missing link?
Patil, M., Singh, S., Henderson, J., & Krishnamurthy, P. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30109 · Cited by 41
Wruck, W., & Adjaye, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-78402-2 · Cited by 45
Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit
Kandeel, M. K., Yamamoto, M., Tani, H., Kobayashi, A., Gohda, J., Kawaguchi, Y., Park, B. K., Kwon, H., Inoue, J., & Alkattan, A. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.201 · Cited by 41
Lin, X., Liu, Y., Chemparathy, A., Pande, T., Russa, M. F. L., & Qi, L. S. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100245 · Cited by 41
In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease
Heinen, N., Klöhn, M., Steinmann, E., & Pfaender, S. (2021) · Viruses · doi:10.3390/v13050792 · Cited by 41
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
Chitsike, L., & Duerksen-Hughes, P. J. (2021) · Virology Journal · doi:10.1186/s12985-021-01624-x · Cited by 45
COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis
Etienne, E. E., Nunna, B. B., Talukder, N., Wang, Y., & Lee, E. S. (2021) · Bioengineering · doi:10.3390/bioengineering8070098 · Cited by 40
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
Iacob, S. A., & Iacob, D. G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01224 · Cited by 42
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D. J., Li, S.-Y., Li, Y., & He, Y.-W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1859-y · Cited by 41
Single‐Cell Microgels for Diagnostics and Therapeutics
Dubay, R., Urban, J. N., & Darling, E. M. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009946 · Cited by 40
Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040793 · Cited by 43
Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19
Maruhashi, T., & Higashi, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105131 · Cited by 40
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection
Rochette, L., & Ghibu, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157979 · Cited by 41
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
Wu, C., Xu, Q., Wang, H., Tu, B., Zeng, J., Zhao, P., Shi, M., Qiu, H. Y., & Huang, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.004 · Cited by 43
Saso, W., Yamasaki, M., Nakakita, S., Fukushi, S., Tsuchimoto, K., Watanabe, N., Sriwilaijaroen, N., Kanie, O., Muramatsu, M., Takahashi, Y., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010590 · Cited by 40
A SARS-CoV-2 mRNA Vaccine — Preliminary Report
Schaefer, J. R., Sharkova, Y., & Nickolaus, T. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2026616 · Cited by 40
Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
Olwenyi, O. A., Dyavar, S. R., Acharya, A., Podany, A. T., Fletcher, C. V., Ng, C. L., Reid, S. P., & Byrareddy, S. N. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01961-4 · Cited by 39
Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results
Pirker-Kees, A., Platho-Elwischger, K., Hafner, S., Redlich, K., & Baumgartner, C. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000515575 · Cited by 40
Ntatsoulis, K., Karampitsakos, Τ., Tsitoura, E., Stylianaki, E.-A., Matralis, A. N., Tzouvelekis, A., Antoniou, K. M., & Aidinis, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687397 · Cited by 41
Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
Maiese, K. (2023) · Biomolecules · doi:10.3390/biom13050816 · Cited by 39
The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19
Sifat, A. E., Nozohouri, S., Villalba, H., Vaidya, B., & Abbruscato, T. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000170 · Cited by 40
Borisova, Т., & Комісаренко, С. В. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-11183-3 · Cited by 39
Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19
Surnar, B., Kamran, M. Z., Shah, A. S., & Dhar, S. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00179 · Cited by 39
Decoding Covid-19 with the SARS-CoV-2 Genome
Ellis, P., Somogyvári, F., Virok, D. P., Noseda, M., & McLean, G. R. (2021) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00197-5 · Cited by 39
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
Chiappalupi, S., Salvadori, L., Vukašinović, A., Donato, R., Sorci, G., & Riuzzi, F. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119251 · Cited by 39
Erçelen, N., Uyanık, K. Ç. P., Alpaydin, N., Gulay, G. R., & Simsek, M. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10214-x · Cited by 39
Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
Beshbishy, A. M., Oti, V. B., Hussein, D. E. E., Rehan, I. F., Adeyemı, O. S., Rivero-Pérez, N., Zaragoza-Bastida, A., Shah, M. A., Abouelezz, K., Hetta, . F., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.591982 · Cited by 41
Age-Associated Neurological Complications of COVID-19: A Systematic Review and Meta-Analysis
Sullivan, B. N., & Fischer, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653694 · Cited by 40
The Role of Endothelium in COVID-19
Ionescu, M., Stoian, A. P., Rizzo, M., Şerban, D., Nuzzo, D., Mazilu, L., Suceveanu, A., Dascălu, A. M., & Parepa, I. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111920 · Cited by 39
Brocke, S. A., Billings, G. T., Taft-Benz, S., Alexis, N. E., Heise, M. T., & Jaspers, I. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00362.2021 · Cited by 40
Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?
Luca, D. D., Vauloup‐Fellous, C., Benachi, A., & Vivanti, A. J. (2023) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2023.101429 · Cited by 39
Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2
Smet, V. D., Verhulst, S., & van Grunsven, L. A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.030 · Cited by 39
Sahai, A., Bhandari, R., Koupenova, M., Freedman, J. E., Godwin, M., McIntyre, T. M., Chung, M. K., Iskandar, J., Kamran, H., Aggarwal, A., et al. (2020) · doi:10.21203/rs.3.rs-119031/v1 · Cited by 39
Yan, C., Zhang, Z., Bao, S., Hou, P. K., Zhou, M., Xu, C., & Sun, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.05.018 · Cited by 38
COVID‐19 breakthroughs: separating fact from fiction
Dhillon, P., Breuer, M., & Hirst, N. L. (2020) · FEBS Journal · doi:10.1111/febs.15442 · Cited by 42
On the genetics and immunopathogenesis of COVID-19
Jacob, C. O. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108591 · Cited by 39
Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review
Ehaideb, S. N., Abdullah, M. L., Abuyassin, B., & Bouchama, A. (2020) · Critical Care · doi:10.1186/s13054-020-03304-8 · Cited by 39
Mpekoulis, G., Frakolaki, E., Τaka, S., Ioannidis, A., Vassiliou, A. G., Kalliampakou, K. I., Patas, K., Karakasiliοtis, I., Aidinis, V., Chatzipanagiotou, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253458 · Cited by 38
Zhang, Y., Sun, S., Du, C., Hu, K., Zhang, C., Liu, M., Wu, Q., & Dong, N. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102643 · Cited by 39
Liu, T., Jia, P., Fang, B., & Zhao, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.603509 · Cited by 38
Suresh, V., Parida, D., Minz, A. P., Sethi, M., Sahoo, B. S., & Senapati, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.579330 · Cited by 38
Pozzi, G., Masselli, E., Gobbi, G., Mirandola, P., Taborda‐Barata, L., Ampollini, L., Carbognani, P., Micheloni, C., Corazza, F., Galli, D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091273 · Cited by 38
A new possible route of airborne transmission caused by the use of a physical partition
Ye, J., Ai, Z., & Zhang, C. (2021) · Journal of Building Engineering · doi:10.1016/j.jobe.2021.103420 · Cited by 38
Ellinghaus, D., Uellendahl-Werth, F., Maj, C., Borisov, O., Juzėnas, S., Wacker, E. M., Jørgensen, I. F., Steiert, T., Bej, S., International Parkinson's Disease Genomics Consortium (IPDGC) (Illig, T. ;. L., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03031-6 · Cited by 38
Calvo, F. R., Padín, J., Muñoz-Rodriguez, J., Serrano-Oviedo, L., López-Juárez, P., Porras-Leal, M., González-Gasca, F., Martínez, M. R., Serrano, R. P., Cadena, A., et al. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13776 · Cited by 39
Gómez‐Carballa, A., Calle, I. R., Pardo‐Seco, J., Rial, J. G., Rivero-Velasco, C., Rodríguez‐Núñez, N., Barbeito‐Castiñeiras, G., Pérez-Freixo, H., Cebey‐López, M., Barral‐Arca, R., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112890 · Cited by 39
Genetic Landscape of the ACE2 Coronavirus Receptor
Yang, Z., Macdonald-Dunlop, E., Chen, J., Zhai, R., Li, T., Richmond, A., Klarić, L., Pirastu, N., Ning, Z., Zheng, C., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057888 · Cited by 39
Metadata
- Authors
- HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., Sampaziotis, F., Worlock, K. B., Yoshida, M., & Barnes, J. L.
- Affiliations
- Wellcome Sanger Institute (GB)
- Centre National de la Recherche Scientifique (FR)
- University Medical Center Groningen (NL)
- Max Delbrück Center (DE)
- Harvard University (US)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- University College London (GB)
- Corresponding author
- Sungnak, Waradon
- ORCID
- Venue
- Nature Medicine
- Published
- 2020-04-23
- Volume
- 26
- Issue
- 5
- Pages
- 681-687
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC8637938
- OpenAlex
- W3011483298
- Cited by
- 2,501
- References
- 59
- Citations by year
- 2026: 53 · 2025: 105 · 2024: 140 · 2023: 265 · 2022: 454 · 2021: 814 · 2020: 664
- FWCI
- 71.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- PubMed Central (acceptedVersion)
- arXiv (Cornell University) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, public-domain)
- Apollo (University of Cambridge) (submittedVersion)
- HAL (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Site cant be reached (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Defense (W81XWH1910416)
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs
- Bill and Melinda Gates Foundation
- Richard and Susan Smith Family Foundation
- Massachusetts General Hospital
- Yale University
- Vanderbilt University
- Massachusetts Institute of Technology
- Memorial Sloan-Kettering Cancer Center
- Northwestern University
- School of Medicine, Boston University
- Arizona State University
- Helsingin Yliopisto
- University of Washington
- Deutsches Zentrum für Infektionsforschung
- Wellcome Trust (211276/Z/18/Z, 211276/D/18/Z, 108082/A/15/Z, #MR/R006237/1, WT206194, 107931/Z/15/Z, GINOP-2.3.2-15-2016-00026, WT211276/Z/18/Z)
- Deutsches Zentrum für Herz-Kreislaufforschung
- European Bioinformatics Institute
- National Jewish Health
- Vanderbilt University Medical Center
- European Molecular Biology Laboratory
- Broad Institute
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Manton Foundation
- University of Alberta
- Cancer Research UK
- National Institute for Health and Care Research (PB-PG-1215-20037, CL-2017-14-001)
- British Heart Foundation (SP/19/1/34461, PG/16/47/32156)
- Cystic Fibrosis Trust (VIA 028)
- Academy of Medical Sciences (SGL019\1071)
- Imperial College London (H2020)
- University College London
- Newcastle University
- European Commission (2018-342, GINOP‐2.3.2‐15‐2016‐00037, 874656, GINOP-2.3.2-15-2016-00006, H2020)
- Rosetrees Trust
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/T2T0419, NC/N001540/1)
- National Research Foundation
- Deutsche Forschungsgemeinschaft (347286815, DK043351, EXC2151/1, EXC 2151, 329123747, 390873048)
- Agence Nationale de la Recherche (ANR‐10‐INBS‐09‐03, ANR- 10-INBS-09, ANR‐19, ANR-19-CE14, ANR-19-CE14-0027, ANR-10, 10-INBS-09, -15-IDEX-01, ANR‐15‐IDEX‐01)
- Fondation Leducq
- Rijksuniversiteit Groningen
- University of New South Wales
- National Natural Science Foundation of China (31871370)
- Catholic University of Korea
- Cancerfonden (2019-)
- Fondation pour la Recherche Médicale (DEQ20180339158)
- National Research Foundation of Korea
- Karolinska Institutet
- National Science and Technology Development Agency
- Kungliga Tekniska Högskolan
- Vetenskapsrådet (2018-)
- Thailand Research Fund
- Centre National de la Recherche Scientifique
- Universitair Medisch Centrum Groningen
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Medizinischen Hochschule Hannover
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Stockholms Universitet
- Science for Life Laboratory
- Conseil Départemental des Alpes Maritimes (2016-294DGADSH-CV)
- Deutsches Zentrum für Lungenforschung
- National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/N001540/1)
- Ministerie van Economische Zaken en Klimaat
- Berlin Institute of Health
- National Institutes of Health (1r56hl135124-01, H2020, AG‐049665, DK 043351, AI135964)
- Directorate for Biological Sciences
- School of Medicine, Duke University
- School of Medicine, Stanford University
- University of California, San Diego
- Harvard Stem Cell Institute
- Feinberg School of Medicine
- Medical School, University of Michigan
- Horizon 2020 Framework Programme (874656, GINOP-2.3.2)
- Klarman Cell Observatory, Broad Institute
- Medical Research Council (MC_PC_17230, MR/R015635/1, MR/P009581/1, MC_PC_12009, MR/R006237/1, MR/K017047/1, MR/S005579/1)
- Engineering and Physical Sciences Research Council (TS/H001220/1)
- Biotechnology and Biological Sciences Research Council (BB/T004460/1, BB/V01126X/1)
- National Health and Medical Research Council
- Faculty of Medical Sciences, Newcastle University
- European Regional Development Fund (GINOP‐2.3.2‐15‐2016‐00006, H2020, GINOP-2.3.2-15-2016-00037, GINOP-2.3.2-15-2016-00026)
- NIHR Newcastle Biomedical Research Centre
- Helmholtz Zentrum München
- NIHR Cambridge Biomedical Research Centre
- National Institute on Aging (P01AG049665)
- National Heart, Lung, and Blood Institute (HL135124, R01HL146557, U01HL148856, R56 HL135124, K08HL130595, K08HL146943, HL148856, U01HL145567, R01HL145372, R01HL127349)
- National Institute of Allergy and Infectious Diseases (U24AI118672, U19AI135964)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD000836)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- SARS-CoV-2, viral entry factors, ACE2, TMPRSS2, nasal epithelial cells, innate immunity, respiratory epithelium, corneal epithelium, intestinal epithelium, tissue tropism, COVID-19 pandemic, single-cell transcriptomics, gene co-expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
